期刊文献+

热疗对肺癌A549细胞P-糖蛋白表达影响的实验研究 被引量:2

Influence of hyperthermia on expression of P-gp in lung cancer A549 cell
下载PDF
导出
摘要 目的研究不同温度、不同加热时间下热疗对肺癌A549细胞P-糖蛋白(P-gp)表达的影响,为肺癌的热疗和热化疗提供理论依据。方法体外复苏与培养肺癌A549细胞;对照组37℃下培养,实验组按不同时间、不同温度分组水浴加热肺癌A549细胞后培养24 h,采用流式细胞术(FCM)观察热处理后的肺癌A549细胞株P-gp表达的变化。结果流式细胞术显示各热疗组A549细胞的P-gp的表达率均较对照组下降,且P-gp的表达率与加热的时间和温度均呈负相关。结论热疗可以抑制P-gp的表达,可能是逆转肿瘤细胞多药耐药的一种手段。 Objective To investigate the influence of hyperthermia on the expression of P-glyeoprotein (P-gp) in lung cancer A549 cell by different temperature and heating time for providing the academic evidence in hyperthermia and thermochemotherapy for lung cancer. Methods To resuscitate and culture the A549 cells in vitro. Control group:AS49 cells were cultivated at 37 ℃. Ex perimental group:A549 cells were cultivated for 24 h after heated by different temperature and heating time. The flow eytometry (FCM) was adopted to observe the influence on the P gp expression of A549 cell treated by thermotherapy. Results The FCM showed hyperthermia could cause reduction of P-gp expression in A549 cell and the expression of P-gp is negative correlation with the heating temperature and heating time. Conclusion Hyperthermia could cause reduction of P gp expression in A549 cell. The re sults suggest that hyperthermia could be used as a method to overcome multidrug resistance.
出处 《重庆医学》 CAS CSCD 北大核心 2010年第6期661-662,共2页 Chongqing medicine
关键词 热疗 肺癌 P-糖蛋白 hyperthermia lung cancer P-glyeoprotein
  • 相关文献

参考文献9

  • 1Takara K, Sakaeda T, Okamura K. An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy[J]. Curr Pharm Des, 2006,12 (3) : 273.
  • 2Marzolini C, Paus E, Bucin T, et al. Polymorphisms in hunman MDR1 (P-glycoproteim) :recent advances and clinical relevance[J]. Clin Pharmacol Ther, 2004,75 ( 1 ) : 13.
  • 3王治伟,杨强,赵渝.肿瘤多药耐药的生化及分子机制[J].重庆医学,2008,37(5):543-545. 被引量:4
  • 4徐建业,周琦,卢萍,汤伟,董莲芳.加温诱导肿瘤细胞凋亡与逆转多药耐药性的实验研究[J].中华理疗杂志,2000,23(1):33-36. 被引量:29
  • 5Liu Y, Lillehei K, Cobb WN, et al. Overcoming MDR by ultrasound-induced hyperthermia and P -glycoprotein modulation[J]. Biochem Biophys Res Commun, 2001,289 ( 1 ) : 62.
  • 6童乾纲,郑家平,叶强,张家兴,汝复明,奚顺法,吴访宏,王德贵,顾伟中.腔内热疗配合放化疗治疗中晚期食管癌[J].世界肿瘤杂志,2004,3(1):84-87. 被引量:19
  • 7廖小莉,胡晓桦,谢伟敏,陆永奎,岑洪,李永强,刘志辉,谭晓虹,周文献.微波热疗对人乳腺癌阿霉素细胞MCF-7多药耐药蛋白及耐药性的影响[J].广西医学,2008,30(8):1126-1128. 被引量:3
  • 8Stein U,Jurchott K,Walther W, et al. Hypermia-indueed nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters[J]. J Biol Chem,2001,276(30) :28562.
  • 9Vilaboa NE,Galan A, Troyano A, et al. Regulation of multidrug resistance 1 (MDR1)/P- glyeoprotein gene expression and activity by heat -shock transcription factor1 (HSF1)[J]. J Biol Chem,2000,275(32) : 24970.

二级参考文献29

共引文献51

同被引文献41

  • 1立彦,王自正.Pgp介导的肿瘤多药耐药逆转研究进展(文献综述)[J].放射免疫学杂志,2005,18(2):133-134. 被引量:14
  • 2Takara K, Sakaeda T, Okumura K. An update on overcoming MDRl-mediated multidrug resistance in cancer chemotherapy [J]. Curr Pharm Des, 2006, 12: 273-286.
  • 3Hirose M. The process behind the expression of mdr-1/P-gp an imp/ MRP in human leukemia/lymphoma [J]. Anticancer Res, 2009, 29 (4): 1073-1077.
  • 4Breier A, Baraneik M, Sulova Z, et al. P-glycoprotein im-plications of metabolism of neoplastic cells and cancer therapy [J]. Curr Cancer Drug Targets, 2005, 5 (6) :457-468.
  • 5Nakajima M, Fujiki Y, Kyo S, et al. Pharmacokineties of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1 [J]. J Clin Pharmacol, 2005, 45(6): 674-682.
  • 6Buda G, Orciuolo E, Maggini V, et al. MDR1 modulates apop tosis in CD34^+ leukemic cells [J]. Ann Hematol, 2008, 87 (12) : 1017- 1018.
  • 7Bergman AM, Pinedo HiM, Talianidis I, et al. Increased sensitivity to gemcitabine of Pglycoprotein and multi-drug ed proteinoverexpressing human cancer cell lines [J]. Br J Cancer, 2003, 88:1963-1970.
  • 8Baumert C, Hilgeroth A. Recent advances in the development ofP-gp inhibitors [J]. Anticancer Agents Med Chem, 2009, 9(4): 415-436.
  • 9Wang Q, Strab R, Kardos P, et al. Application and limitation of in-hibitors in drug-transporter interactions studies [J]. Int J Pharrn, 2008, 356(1-2):12-18.
  • 10Balimane PV, Marino A, Chong S. P-gp Inhibition potential in cell-based models:which "calculation" method is the most accurate? [J]. AAPS J, 2008, 10: 577-586.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部